Mesenchymal tumours represent one of the most challenging field of diagnostic pathology
and refinement of classification schemes plays a key role in improving the quality of …

Highlights•This Clinical Practice Guideline provides key recommendations on the
management of soft tissue and visceral sarcomas.•Recommendations have been agreed …

This paper describes the standard of care for patients with non-rhabdomyosarcoma soft
tissue sarcomas (NRSTS) and the therapeutic recommendations developed by the …

Background The value of neoadjuvant chemotherapy in soft tissue sarcoma (STS) is not
completely understood. This study investigated the benefit of neoadjuvant chemotherapy …

Background A standardised approach to treatment of paediatric non-rhabdomyosarcoma
soft tissue sarcomas (NRSTS), which account for about 4% of childhood cancers, is still …

Reliable tools for prognosis prediction are crucially needed by oncologists so they can tailor
individual treatments. However, the wide spectrum of histologies and prognostic behaviors …

Simple Summary The aim of this review is to provide an overview of the biological basis of
pathogenesis and current research in extraskeletal myxoid chondrosarcoma (EMC) …

Liposarcomas are a common subfamily of soft tissue sarcoma with several subtypes
recognized by the World Health Organization: atypical lipomatous tumors (ALT)/well …

Soft tissue sarcomas (STS) are rare and heterogeneous tumours comprising over 80
different histological subtypes. Treatment options remain limited in advanced STS with high …

Simple Summary High NLR, PLR, and SII are associated with worse PFS in second-line STS
patients. Trabectedin-treated patients have a better PFS when LMR is low, while patients …